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Abstract
Objective—The lesions of Parkinson's disease spread through the brain in a characteristic pattern
that corresponds to axonal projections. Previous observations suggest that misfolded α-synuclein
could behave as a prion, moving from neuron to neuron and causing endogenous α-synuclein to
misfold. Here, we characterized and quantified the axonal transport of α-synuclein fibrils and
showed that fibrils could be transferred from axons to second-order neurons following anterograde
transport.
Methods—We grew primary cortical mouse neurons in microfluidic devices to separate soma
from axonal projections in fluidically isolated microenvironments. We used live-cell imaging and
immunofluorescence to characterize the transport of fluorescent α-synuclein fibrils and their
transfer to second-order neurons.
Results—Fibrillar α-synuclein was internalized by primary neurons and transported in axons
with kinetics consistent with slow component-b of axonal transport (fast axonal transport with
saltatory movement). Fibrillar α-synuclein was readily observed in the cell bodies of second-order
neurons following anterograde axonal transport. Axon-to-soma transfer appeared not to require
synaptic contacts.
Interpretation—These results support the hypothesis that the progression of Parkinson's disease
can be caused by neuron-to-neuron spread of α-synuclein aggregates and that the anatomical
pattern of progression of lesions between axonally connected areas results from the axonal
transport of such aggregates. That the transfer did not appear to be transsynaptic gives hope that
α-synuclein fibrils could be intercepted by drugs during the extra-cellular phase of their journey.
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Parkinson's disease (PD) is a common neurodegenerative disorder, second in frequency only
to Alzheimer's disease. PD can cause cognitive impairment as well as movement disorders1.
α-Synuclein is the major component of Lewy bodies and Lewy neurites, the filamentous
inclusions characteristic of PD and other “synucleinopathies” such as dementia with Lewy
bodies and multiple system atrophy. Besides being diagnostic of this group of diseases, the
accumulation of aggregated proteins including α-synuclein is thought to play a role in
neurodegeneration. α-Synuclein is a 140-amino acid protein that adopts an α-helical
structure when bound to membranes but can also fold into a β-sheet-rich structure that
polymerizes into fibrils and protein aggregates2. It has been hypothesized that aggregated α-
synuclein might behave like a prion, capable of initiating misfolding and aggregation of
nascent or even properly folded α-synuclein3,4,5,6. The prion hypothesis is supported by the
observation that young mice of the M83 line, a transgenic line which overexpress the A53T
mutant human α-synuclein, develop a motor disease with insoluble α-synuclein deposits in
the CNS following intracerebral inoculation with brain homogenates from old M83 mice7,8.
The lesions of PD progress along an ascending pattern that corresponds to anatomical
connections between brain structures. For example, early lesions predominate in olfactory
bulbs and appear to spread in an anterograde direction from there to the limbic system and
the neocortex9. Similarly, the lesions of the substantia nigra appear to spread to the striatum,
and those of the ventral tegmental area to the cortex, in both cases following anterograde
axonal pathways9. These patterns may be interpreted as resulting from axonal transport of an
“infectious”, or at least self-propagating, form of α-synuclein followed by spread to a higher
order neuron. This spread could involve either lysis of the first neuron or a non-lytic
unconventional secretion pathway.
Host-to-graft propagation of Lewy bodies was recently demonstrated at autopsy in PD
patients who had received neuronal grafts decades earlier10,11, an observation that has been
reproduced in a mouse model12. However, it is not yet known whether the aggregation of α-
synuclein in the grafts is due to the spread of the misfolded α-synuclein or to the spread of
conditions conducive to α-synuclein aggregation. Consistent with the first scenario, the
release of misfolded α-synuclein by cultured cells, including neurons, has been documented,
as has the ability of cultured cell lines, including those of neural origin, to take up
aggregated α-synuclein from culture medium12-14. Findings consistent with transmission of
α-synuclein between co-cultured neurons have been reported previously, although the role
of axonal transport in this transmission was not addressed15. In the present paper, we used
microfluidic chambers to characterize the axonal transport of α-synuclein fibrils. We show
that this transport proceeds with velocities characteristic of fast axonal transport with “stop
and go” phases, a type of transport referred to as slow component-b of axonal transport16,17.
Importantly, we have demonstrated the transfer of axonally transported fibrillar α-synuclein
to the soma of second order neurons.
Materials and methods
Cells
The cortices of E17 mouse embryos were incubated in 0.125% trypsin in Earle's balanced
salt solution for eight minutes at 37°C and re-suspended in 10 ml of Dulbecco's modified
Eagle medium (DMEM) containing 10% fetal bovine serum. Digested material was
centrifuged at 2500rpm for 2min; re-suspended in 1ml of Neural Basal Media (NBM)
containing 2% B27 and 0.25% Glutamax (All from Invitrogen (Carlsbad, CA, USA)); then
triturated through three glass pipettes of decreasing diameter. After centrifugation as before,
the pellet was re-suspended in 250 μl/cortex of supplemented NBM and filtered though a
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40μm cell strainer (BD Biosciences, Bedford, MA, USA). Microfluidic culture devices were
obtained from Xona microfluidics (Temecula, CA, USA). After plasma bonding to glass
coverslips, the devices were coated with poly-D-lysine (Sigma, St Louis, MO, USA) and
mouse laminin (Cultrex, Lake Forest, CA, USA). Fifteen microliters of neuron-containing
suspension were seeded in the soma channel. Incubation was at 37°C, 10% CO2, in a
humidified incubator.
A modified technique that reduces glial cell contamination was used for some experiments.
Briefly, trypsin was replaced by 10units/ml of papain in phosphate buffered saline (PBS) for
15min at 37°C. The medium was changed to PBS with Ca++ and Mg++ containing 75mg/ml
BSA, 75mg/ml trypsin inhibitor and 1mg/ml DNase I. After 5min, the medium was replaced
by PBS without Ca++ and Mg++ containing 75mg/ml bovine serum albumin (BSA) and
75mg/ml trypsin inhibitor and the tissues were triturated by repeated pipetting through at
1ml pipet tip (Pipetman). After filtration though a 40μm cell strainer and centrifugation at
1000rpm for 10min at room temperature, the cells were resuspended in 5 ml of NBM,
layered on top of 3ml of 4% BSA in NBM and centrifuged as above. The cell pellet was
resuspended in 10μl per cortex of supplemented NBM. The cell density was adjusted to 106
cells/5μl and 5μl of suspension were seeded in the soma channel.
Preparation of fibrillar Alexa Fluor 488- and ATTO 550-labeled α-synuclein
Recombinant wild-type α-synuclein was expressed in E. coli strain BL21(DE3) (Stratagene,
Santa Clara, CA, USA) and purified as described18. The fibrillar form of the protein was
generated and labeled with NHS-ester Alexa Fluor 488 (Invitrogen, Carlsbad, CA, USA) or
NHS-ester ATTO-550 (ATTO-TEC GmbH, Siegen, Germany) as described12. The fibrillar
nature of α-synuclein was assessed using a Jeol 1400 transmission electron microscope
following adsorption onto carbon-coated 200-mesh grids and negative staining with 1%
uranyl acetate. The images were recorded with a Gatan Orius CCD camera (Gatan,
Pleasanton, CA, USA).
Preparation of Alexa 555- labeled fibrillar Aß42 peptide and Alexa 555-labeled BSA
Primers 5’-CCCGGGAATTCCATATGGACGCGGAATTTCGCCATGATAGCGGC-3’
and 5’-TCCGCGGGATCCCTACTATGCAATCACGACGCCTCCGACC-3’ were used to
amplify the Aß42 peptide with an N-terminal Met codon. Amplified DNA was cloned into
the pET3a vector (Novagen) between the NdeI and BamH1 restriction sites and expressed in
E. Coli. strain BL21(DE3) codon+ (Stratagene, Santa Clara, CA, USA). Recombinant
Aß1-42 was purified as described19. Met-Aß1-42 was diluted in PBS to a concentration of
100μM and incubated at 37°C for 5 days. Fibrillar Met-Aß1-42 was labeled with Alexa 555
as described for fibrillar α-synuclein12. Aliquots were flash frozen in liquid nitrogen, and
stored at -80°C. BSA (Sigma, St Louis, MO, USA), 1 mg/ml in PBS, was labeled with
Alexa 555 and purified as described for fibrillar α-synuclein12.
Immunostaining
Cells were incubated with Calcein AM and visualized live or incubated with Alexa Fluor
555-labeled cholera toxin B (both from Invitrogen, Carlsbad, CA, USA) for 30min then
fixed with 4% paraformaldehyde in PBS and washed once with PBS. Antibodies were
diluted in PBS containing 2% BSA, 2% normal goat serum and 0.2% Triton X-100. Anti-
class III ß-tubulin (Neuromics, Edina, MN, USA) was diluted 1:1000. Anti-phosphorylated
neurofilament, clone SMI 31 (Covance, Princeton, NJ, USA) was diluted 1:1000. Incubation
with primary antibody was for 3hr followed by 5 washes in PBS and a 1hr incubation with a
1:1000 dilution of secondary antibodies (Invitrogen, Carlsbad, CA, USA). Incubations were
at room temperature. Cells were covered with Vectashield containing DAPI (Vector
Laboratories, Burlingame, CA) after 5 washes in PBS.
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Microscopy and spectral analysis
Confocal microscopy was done with a Leica SP2 microscope equipped with a UV-405 laser.
For spectral analysis, a region of interest was selected and the emission intensity was
measured in increments of 5nm. Leica application suite software was used for quantitation.
Live cell imaging was done with a Nikon Eclipse Ti inverted microscope (60x and 100x oil
objectives). The microfluidic devices were maintained at 37°C with 10% CO2 during
acquisition at either 80ms time intervals for 80s or 500ms intervals for 250s. Time-series
images were analyzed using Fiji software (http://fiji.sc/wiki/index.php/Fiji). Segments of
axons that showed puncta movements were traced and kymographs were made for each
region of interest. Average and maximum velocities of punctae were calculated from the
kymographs.
Results
Uptake of α-synuclein fibrils by primary neurons
To determine whether primary cortical neurons could internalize purified α-synuclein
fibrils, Alexa Fluor 488-labeled fibrils (Fig 1A) were added to the medium of one-week-old
cultures to a final concentration of 6nM. After 24 hours, the cells were fixed,
immunostained, and analyzed by confocal microscopy. Alexa Fluor 488 containing punctae
could be readily identified within the cytoplasm of cells that expressed the neuronal marker
β-III tubulin (Fig 1B), confirming results previously published by others12-14. The
colocalization of fibrils and β-III tubulin demonstrated their cytoplasmic position. Both
neuronal and non-neuronal cell types contained fibrillar α-synuclein (Fig 1B).
Anterograde axonal transport of α-synuclein fibrils
We utilized microfluidic devices20, to separate neuronal cell bodies from their axons and
from second-order neurons that would be contacted by those axons (Supplemental Fig 1).
Fluidic isolation was achieved by maintaining a volume difference of 100μl between the
soma and axon chambers. Isolation has been demonstrated previously 19. We confirmed that
isolation was achieved in our set up using a 30-nm virus, smaller than the α-synuclein fibrils
(see Fig 1), and an extremely sensitive infectivity assay with a detection limit of 3 plaque
forming units. We could not detect any infectivity in the opposite chambers after 32h of
incubation (Supplemental Fig 1C).
Primary neurons were seeded on one side of such a microfluidic device and cultured for one
week. Numerous extensions had entered the opposite channel through the 450-nm long
microgrooves, as shown by adding Calcein AM to the culture. Immunolabeling with the
anti-neurofilament antibody SMI 31 showed that these extensions were axons (Supplemental
Fig 2).
To determine whether the α-synuclein fibrils could be transported along these axons in an
anterograde direction, Alexa Fluor 488-labeled fibrils (Syn-488) were introduced into the
chamber containing the neuron cell bodies together with Alexa Fluor 555-labeled cholera
toxin B (CtB-555) to label cellular membranes. The microgrooves were observed by
confocal microscopy after 4-5 hours of incubation. Fluorescent punctae were observed
associated with axons (Fig 1C), strongly suggesting that fibrillar α-synuclein had arrived
there by anterograde transport from the cell body.
We compared the emission spectra of punctae, in confocal optical sections, with those of the
dyes used in the experiment. Figure 1D shows the emission spectrum of the punctum shown
in Figure 1C, of Alexa Fluor 488-labeled fibrils alone, and of the green background
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autofluorescence observed in formaldehyde-fixed frozen brain sections. Brain was chosen as
a control because no such background was observed in the primary neuron cultures. Figure
1D shows that the spectrum of the punctum within the axon was similar to that of the labeled
fibrils and distinct from autofluorescence, arguing that such punctae correspond to fibrillar
α-synuclein. The emission spectrum for cholera toxin B was the same for both the soma
compartment and the structures that surrounded the punctum, arguing that the fibrils were
surrounded by axonal membranes. Thus, the fibrils introduced in the soma compartment
could be unambiguously identified, shown to be internalized by neurons and transported
axonally in an anterograde direction.
Characterization of the axonal transport of α-synuclein fibrils
We quantified anterograde axonal transport of α-synuclein fibrils using live-cell imaging.
The neuron isolation protocol was modified (Materials and Methods) to reduce the number
of astrocytes and to increase the number of axons in the microgrooves. Using anti-ß-III
tubulin and anti-GFAP antibodies we found that approximately 50% of the cells were
neurons and 50% were astrocytes (not shown). In a typical culture approximately 600 axons
emerged from the microgrooves after one week. ATTO550-labeled α-synuclein fibrils
(1.5nM) were added to the soma compartment of such cultures and the movement of punctae
was characterized 4-5 hr later. A large number of moving punctae were readily observed
within the microgrooves as well in the axons in the axon channel (Fig 2A and Supplemental
Movies 1 and 2).
To characterize the movements of punctae in axons, images were collected at 80ms or
500ms intervals, depending on the experiment, for up to 500s. The velocity of punctae was
measured along a defined region of interest (ROI) of an axon, as shown in Figure 2B and
displayed as kymographs (Fig 2C, D). A total of 52 punctae on 26 axonal segments were
analyzed. Images from the microgrooves allowed unambiguous distinction between
anterograde and retrograde movements. Three types of movement were observed: a steady
anterograde movement with an average velocity of 163μm/min, consistent with fast axonal
transport (Fig 2D); punctae moving at a similar velocity but pausing for various lengths of
time between phases of movement (Fig 2D); finally punctae with complex kinetics that
displayed periods of movement at various velocities and periods of rest (Fig 2C). Overall
these kinetics are characteristic of slow component-b of axonal transport16,17. On occasion,
as in Figure 2D, a punctum was observed moving in a retrograde direction. Some punctae
were immobile during the whole recording (Fig 2A and Supplemental Movies 1 and 2).
The signal to noise ratio (SNR) for fluorescence intensity of punctae was used as a measure
of size since the molecules of α-synuclein were uniformly labeled with a covalently linked
fluorochrome. We observed a moderate negative association between both maximum and
average velocity and SNR (Fig 3). Small punctae displayed a large range of velocities up to
a maximum of around 400μm/min. Their average and maximum velocities were nearly
identical, which demonstrates that they did not pause during recording. The velocity of large
punctae decreased as their size increased. The decrease of average velocity resulted from
both decreased maximum velocity and a larger number, and/or length, of pauses.
Transmission of α-synuclein fibrils to second-order neurons following anterograde axonal
transport
We tested whether α-synuclein fibrils could be transmitted to second-order neurons
following anterograde transport. Neurons cultured in one channel were allowed to extend
axons in the opposite channel for one week. α-Synuclein fibrils were then added to the soma
of these neurons and, at the same time, freshly isolated neurons were added to the axonal
compartment to serve as potential recipient cells (Fig 4C). A volume excess of 100μl was
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maintained in the recipient neuron chamber. After 4 days, fluorescent punctae were readily
observed in recipient cells (Fig 4D). Staining with an anti ßIII-tubulin antibody and confocal
microscopy showed that both neurons and non-neuronal cells had internalized axonally
transported α-synuclein fibrils (Fig 4D). Colocalization between punctae and β-III tubulin
demonstrated their intracytoplasmic localization in neurons. As a control for a possible
retrograde transport of α-synuclein fibrils into the soma of the recipient neurons, fibrils and
neurons were introduced into opposite chambers of an empty device and the culture was
incubated for four days. A volume excess of 100μl was maintained in the chamber with
neurons (Fig 4A). As illustrated in Figure 4B, no background retrograde transport to the
recipient neurons was observed. We therefore conclude that fibrillar α-synuclein can be
transferred to the cell body of second-order neurons following anterograde transport.
We used the modified protocol for neuron culture to measure the efficiency of axon to
recipient cell transfer more precisely. The setup of the experiment was as shown in Figure
4C except that after adding fibrils in the first neuron channel and recipient neurons in the
other channel, the culture was continued for only 24hr, then fixed and reacted with an anti-
ßIII-tubulin antibody. The total number of fluorescent, fibril-containing cells in the recipient
channel was determined by systematically scanning the entire channel with a 45x objective.
In the experiment described in Figure 4E, there were 572 such cells. Twenty to 24 fields that
contained positive cells in both the first neuron channel and the recipient channel were
selected and examined by confocal microscopy to determine the percentage of fibril-
containing cells that were neurons. Out of 483 and 572 fibril positive cells examined in the
first neuron channel and the recipient channel, respectively, approximately 50% were
neurons (Fig 4E). The other half must have been astrocytes since these cultures are made of
50% neurons and 50% astrocytes.
Finally, we examined if the fibrillar form of the Aß42 peptide, associated with Alzheimer
disease, behaved in the same way as α-synuclein in the microfluidic device. Bovine serum
albumin (BSA) was also tested as a control soluble protein. Both proteins were labeled with
Alexa-555 fluorochrome in parallel with α-synuclein and run in parallel in an experiment
analogous to that shown in Figure 4. Interestingly, after 24h of incubation, the Aß42 peptide
fibrils gave punctae that appeared in neurites of the first neurons (Supplemental Figure 3A),
and in axons both in the microgrooves and the axon channel (Supplemental Figure 3B,C).
Some rare punctae were observed in the soma of second-order neurons (not shown). BSA,
on the other hand, although it may have been internalized by neurons (Supplemental Figure
3D), was not detected in axons in the axon channel or in second-order neurons (not shown).
Discussion
In this study, we demonstrate that α-synuclein fibrils are internalized, anterogradely
transported within axons, released, and subsequently taken up by additional neurons.
Transfer of α-synuclein fibrils to neuronal soma following axonal transport may explain the
characteristic pattern of spread of Lewy bodies between anatomically connected brain areas,
in particular from the limbic system to the neocortex where misfolding of α-synuclein is
responsible for PD-associated dementia. Although the mechanism of lesion formation
following such axonal transport and uptake is outside the scope of our study, there is
accumulating evidence that α-synuclein fibrils might behave as prions and seed the
misfolding of endogenous α-synuclein3-8. Therefore, the data presented here may explain an
important aspect of PD pathogenesis.
The punctae present in axons were of various sizes, which appeared to influence the rate of
their transport. An analysis of velocity as a function of size shows that both maximum
velocity and average velocity decreased as punctum size increased. More surprising was the
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observation that small punctae showed a large range of velocities that extends from 10μm/
min to 400μm/min (Fig 3). Since the average velocity of many of these punctae was equal to
their maximum velocity, this variation cannot be explained by pauses of varying length, at
least at a level that could be detected under our conditions. This type of movements
corresponds to what has been described as slow component-b of axonal transport16,17.
Interestingly, endogenous, soluble α-synuclein, is transported as part of a large cargo of
many different proteins with kinetics that also correspond to slow component-b16,17,21,22.
Our results may indicate that, following internalization by soma or dendrites, fibrillar α-
synuclein finds its way into the pathways that address cargo of iterative protein complexes
to the axon hillock and the microtubule-dependent machinery responsible for this class of
transport.
Interestingly, uptake by neuron soma and anterograde axonal transport was also observed for
fibrils of Aß42 peptide, but not for a soluble protein (BSA) (Supplemental Figure 3). Our
observation with the Aß42 peptide may have important implications for the pathogenesis of
Alzheimer disease. However, this is outside of the scope of the present article. The similar
behavior of α-synuclein and Aß42 fibrils indicates that axonal transport of protein
assemblies is not necessarily determined by the nature of the proteins but rather by the
repetitive nature of the cargo. The efficiency of transfer of α-synuclein fibrils from axons to
a second-order neuron appears to be low, although the experimental set up did not allow for
a real measurement of efficiency. In the experiment described in Figure 4, fluorescent
punctae were found in 286 of the 5×105 second-order neurons introduced in the channel.
Obviously, such ratio depends on the number of second-order neurons, which was arbitrary.
It may be more telling to consider that the punctae that were observed in approximately 300
neurons and 300 glial cells after 24h had been introduced into the second-neuron channel by
approximately 600 axons.
The mechanism of exit of fibrillar α-synuclein from axons and of uptake by neuronal soma
deserves close examination. In particular the respective roles of axonal lysis and of
unconventional secretion in exit, and the role of synaptic contacts in transfer, remain to be
more directly investigated. Our findings suggest that transfer can occur in the absence of
synapses since their formation in mixed E17 murine neuron/astrocyte cultures requires 2 to 3
weeks (Ben Barres, personal communication), whereas the second order-neurons had been
cultivated for only 1 or 4 days, depending on the experiment. Also, we observed that the
axons emerging from the microgrooves and the second neurons were not in the same plane.
Axons tend to adhere to the PDMS “ceiling” of the channel whereas the recipient neurons
and astrocytes adhered to the glass “floor”, the two being separated by 100μm
(Supplemental Figure 4). Therefore, our results suggest that fibrillar α-synuclein exited the
axons and entered the extracellular milieu prior to cellular uptake. If axon-to-soma
transmission of misfolded α-synuclein occurs by a similar mechanism in the CNS, this
extracellular step may represent an opportunity to intercept fibrillar α-synuclein with drugs
which could inhibit the progression of PD and other synucleinopathies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Internalization and anterograde axonal transport of α-synuclein by primary neurons. (A)
Alexa Fluor 488-labeled α-synuclein fibrils (Syn-488) were imaged by transmission
electron microscopy. Scale bar = 200nm. (B) Fibrils were added to primary cortical neurons
and incubated for 24 hours. Cells were reacted with an anti-ß-III tubulin antibody to identify
neurons, stained with DAPI to identify nuclei and observed by confocal microscopy. Scale
bars = 10μm. (C) Anterograde axonal transport of α-synuclein fibrils. Alexa Fluor 488-
labeled fibrillar α-synuclein (Syn-488) and Alexa Fluor 555-labeled cholera toxin subunit B
(CtB) were added to the soma of cortical neurons in a microfluidic device. A volume
difference was maintained to prevent passive diffusion of fibrillar α-synuclein into the
opposite chamber. Axons within microgrooves were visualized by confocal microscopy.
Areas of green fluorescence are indicated by arrows. The lower panel shows higher
magnification of the boxed region. (D) Emission spectra of the regions of interest (box)
shown in C. Spectra were compared with those of pure Syn-488 deposited on a microscope
slide and of the red fluorescence in soma and axons (CtB-555). A typical autofluorescence
signal was determined using an unrelated CNS tissue sample.
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Kinetics of axonal transport of α-synuclein fibrils. (A) Representative field of time-lapse
analysis for an axon in a microgroove. The two bright lines correspond to the edges of the
microgroove. The red arrow indicates the movement of a punctum through an axon. The
time is given in seconds in the upper left hand corner of each image. Soma is to the left. (B)
Selection of axon segment for velocity and flux measurements. (C) Kymograph of the
punctum from (A) as it traveled through the axonal segment highlighted in (B) over a 250s
time interval. (D) A kymograph showing a variety of punctum movements, including three
punctae with fast-anterograde movement (I), one punctum with a saltatory movement with a
long pause (II), and one punctum that appears to move in a retrograde direction (III).
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Relationship between the velocity of punctae and their size. (A) The average velocity is
plotted against the signal-to-noise ratio (SNR) of the fluorescence of each punctum. (B) The
maximum velocity is plotted against the SNR for each punctum. The Pearson product-
moment correlation coefficient (r) and the linear association trend line are shown for both
(A) and (B).
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Axonal transport and transmission of α-synuclein fibrils to second order neurons. (A) Set up
of the control experiment to determine background retrograde transport. Syn-488 fibrils
were added to one chamber that did not contain neurons. At the same time, recipient neurons
were plated in the opposite channel that was given an additional 100μl of medium to prevent
diffusion. (B) After four days of incubation the cells were stained with an anti-class III ß-
tubulin (ßIII-tubulin) antibody to identify neurons and imaged by confocal microscopy. The
upper and lower panels show two representative fields. (C) Schematic of the experimental
setup to detect and measure transfer. Neurons were plated and cultured for one week to
allow them to extend their axons to the opposite channel. At that time, Syn-488 fibrils were
added to the chamber containing these neuron soma and freshly isolated neurons were added
to the opposite channel. After one or four days in culture, depending on the experiment, the
cells in both channels were stained with an anti-ßIII-tubulin antibody and analyzed by
confocal microscopy. (D) The upper and lower panels show two representative fields. (E)
For the experiments schematized in C, the percentages of Syn-488-positive cells that were
neurons was determined by a blinded experimenter for the first neuron channel and the
recipient channel. Graphs show individual values as well as mean ± SEM.
Freundt et al. Page 13
Ann Neurol. Author manuscript; available in PMC 2013 October 01.
$w
aterm
ark-text
$w
aterm
ark-text
$w
aterm
ark-text
